Table 2.
Clinical characteristics of the BC patients (n = 68).
| Characteristics | Total cases, N | % |
|---|---|---|
| Age at diagnosis (years) | ||
| ≤50 | 32 | 47.06 |
| >50 | 36 | 52.94 |
| Molecular subtype | ||
| Triple-negative | 6 | 8.82 |
| HER2+ (any ER/PR) | 14 | 20.59 |
| HER2− (ER or/and PR+) | 48 | 70.59 |
| Tumor size (cm) | ||
| ≤2 | 31 | 45.59 |
| >2 | 37 | 54.41 |
| Tumor stage | ||
| I/II | 41 | 60.29 |
| III/IV | 27 | 39.71 |
| Metastatic status | ||
| No | 36 | 52.94 |
| Yes | 32 | 47.06 |
| Distant metastatic status | ||
| No | 55 | 80.88 |
| Yes | 13 | 19.12 |
HER2: human epidermal growth factor receptor 2; ER/PR: estrogen/progesterone receptor.